Executive Development Programme in Pharmacovigilance Reporting and Documentation

This course is designed for pharmaceutical industry professionals, including pharmacovigilance officers and compliance managers, who need to enhance their skills in pharmacovigilance reporting and documentation. Participants will gain a comprehensive understanding of regulatory requirements, learn to identify and report adverse drug reactions effectively, and master best practices for documenting and managing safety data.

Upon completion, attendees will be proficient in adhering to global pharmacovigilance standards, capable of conducting thorough risk assessments, and adept at maintaining high-quality, compliant records to ensure patient safety and regulatory compliance.

1. 1. Introduction to Pharmacovigilance: Learners will study the basic principles and importance of pharmacovigilance, including its definition, scope, and regulatory requirements. They will gain foundational knowledge to understand the role of pharmacovigilance in ensuring public health safety.
2. 2. Regulatory Framework and Guidelines: This module will cover key regulatory bodies and guidelines related to pharmacovigilance, such as the International Council for Harmonisation (ICH) guidelines. Learners will understand how to apply these guidelines in their work to ensure compliance.
3. 3. Data Collection and Management: Learners will study methods for collecting and managing adverse event data, including data entry, validation, and storage. Practical skills in using electronic data capture systems and ensuring data integrity will be developed.
4. 4. Signal Detection and Analysis: This module focuses on techniques for detecting signals in adverse event data, including statistical methods and tools for analyzing trends and patterns. Learners will gain the ability to identify potential safety issues from large datasets.
5. 5. Case Report Form Design and Development: Learners will learn how to design and develop case report forms (CRFs) that capture essential information for pharmacovigilance reports. They will understand the importance of CRFs in ensuring the quality and completeness of data.
6. 6. Reporting Adverse Events: This module covers the procedures and guidelines for reporting adverse events to regulatory agencies, including the format and content of reports. Practical skills in writing clear and comprehensive adverse event reports will be developed.
7. 7. Risk Management and Mitigation: Learners will study methods for risk management and mitigation in pharmacovigilance, including risk assessment and the design of risk minimization action plans. They will learn how to implement these strategies effectively.
8. 8. Legal and Ethical Considerations: This module will explore legal and ethical issues in pharmacovigilance, including confidentiality, privacy, and patient rights. Learners will understand the importance of adhering to ethical standards in their work.
9. 9. Pharmacovigilance Software and Tools: Learners will be introduced to various software and tools used in pharmacovigilance, including data analysis software and electronic safety reporting systems. Practical skills in using these tools for pharmacovigilance activities will be developed.
10. 10. Continuous Improvement in Pharmacovigilance: This final module focuses on strategies for continuous improvement in pharmacovigilance practices. Learners will learn how to evaluate the effectiveness of their systems and processes and implement changes to enhance safety and quality.